Effects of Remotely Supervised Home-Based High-Speed Bodyweight Resistance Training on Bradykinesia in Individuals With Parkinson Disease: Protocol for a Randomized Controlled Trial. Research JMIR research protocols May 4, 2026
Phenoconversion in Pure Autonomic Failure: A Systematic Review and Meta-Analysis. Research JAMA neurology May 4, 2026
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients. Trial Phase 1 Recruiting May 3, 2026
" Visual Characterization of Parkinson's Patients and Oculomotor or Perceptual Therapy" Trial N/A Completed May 3, 2026
Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease Trial Phase 2 Completed May 3, 2026
Sweating and Parkinsonās: Understanding an Overlooked Symptom News Brian Grant Foundation May 1, 2026
Exposure to Air Pollutants and Lewy Body and Parkinson Disease-Related Dementias. Research JAMA network open May 1, 2026
Exploring In situ neuroprotective mechanisms of nicotine in an MPTP-Induced Parkinson's disease rat model using spatial metabolomics. Research Frontiers in cell and developmental biology May 1, 2026
Effects of different exercises on motor and non-motor abilities in patients with Parkinson disease-a network meta-analysis of randomized controlled trials. Research Frontiers in physiology May 1, 2026
Intermittent Theta-Burst Stimulation for Depressive Symptoms in Parkinson Disease: A Randomized Clinical Trial. Research JAMA network open May 1, 2026
Acute Effects of AMPS on Cardiovascular, Functional Capacity and Postural Control in Patients With Parkinson's Disease Trial N/A Completed April 30, 2026
A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations Trial Phase 1 Not yet recruiting April 30, 2026
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT Trial Early Phase 1 Active, not recruiting April 30, 2026
Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging Trial N/A Not yet recruiting April 30, 2026